Clinical trial
A Pilot Study Evaluating the Correlation Between Carbon 11 Acetate (C-11 Acetate) Uptake and Retention as Measured by Positron Emission Tomography (PET) and Fatty Acid Synthase (FAS) Expression in Prostate Cancer
NCT00139191 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study Evaluating the Correlation Between Carbon 11 Acetate (C-11 Acetate) Uptake and Retention as Measured by Positron Emission Tomography (PET) and Fatty Acid Synthase (FAS) Expression in Prostate Cancer
- Lead sponsor
- Dana-Farber Cancer Institute
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2005
- Completion date
- May 31, 2006
- Enrollment
- 20
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer